−£3.72m
vs Dec 2024Active12294967Private limited companyOxford
OCHRE BIO LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Ochre Bio Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
OCHRE BIO LTD is an active private limited company (company number 12294967) incorporated on 4 November 2019, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of −£3.72m and cash of £4.74m, with 37 employees on average. Net assets rose 8% on the prior period (−£4.06m). Across the last 3 periods on record the net-asset trend is volatile.
Peer position · net assets
By net assets it sits in the bottom quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
No active person with significant control is registered.
- Quin Wills
- owns 25–50% of shares
- holds 25–50% of voting rights
- Jack O'Meara
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 4 November 20196 yrs ago
- Next accounts due
- 30 September 2027in 342 days
- Confirmation statement due
- 18 November 2026in 26 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£4.74m
−18%vs Dec 2024Not reported
37
+12%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£3.72m | £4.74m | — | £6.72m | — | — | 37 |
| 31 December 2024 | −£4.06m | £5.80m | — | £8.60m | — | — | 33 |
| 31 December 2023 | £1.72m | £2.19m | — | £1.34m | — | — | 33 |
Current ratio1.46Current assets ÷ creditors within one year
Cash per employee£128kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-3,721,489 at 31 December 2025
- Cash at bank of £50,000 or moreCash £4,742,065
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 4 November 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 342 days
- Confirmation statement duein 26 days
- Accounts period endNet liabilities £3.72m · small accounts
- Accounts period endNet liabilities £4.06m · small accounts
- Accounts period endNet assets £1.72m · small accounts
- Incorporated
08
Similar companies in Oxford
- CAVENDISH BIOTECHNOLOGY LTDOxford · inc. Nov 2019
- MABSOLVE LIMITEDOxford · inc. Dec 2019
- SAMSARA THERAPEUTICS LTDOxford · inc. Dec 2019
- OXACUS LTDWallingford · inc. Aug 2019
- SPACE BIOLOGICAL SCIENCES LTD.Bicester · inc. Aug 2019
- GORDIAN PHARMA LIMITEDOxford · inc. Jan 2020
All companies incorporated on 4 November 2019 · in Nov 2019.
09
Reminders for OCHRE BIO LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.